Congenital chronic diarrhea with protein-losing enteropathy Advocacy Hub | UniteRare

At a Glance

Live from database

1 event

Aug 2023

Veopoz: FDA approved

treatment of adult and pediatric patients 1 year of age and older with CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Veopoz

Regeneron Pharmaceuticals, Inc.

OpenContact for detailsApply ↗

No active clinical trials currently recruiting for Congenital chronic diarrhea with protein-losing enteropathy.
Search all trials →

No recent news articles indexed yet for Congenital chronic diarrhea with protein-losing enteropathy.
Search PubMed for Congenital chronic diarrhea with protein-losing enteropathy →

No specialists currently listed for Congenital chronic diarrhea with protein-losing enteropathy.

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants